<VariationArchive RecordType="classified" VariationID="2581559" VariationName="NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del" VariationType="Deletion" Accession="VCV002581559" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-04" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2749138" VariationID="2581559">
      <GeneList>
        <Gene Symbol="LAMA2" FullName="laminin subunit alpha 2" GeneID="3908" HGNC_ID="HGNC:6482" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="128883138" stop="129516566" display_start="128883138" display_stop="129516566" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129204285" stop="129837710" display_start="129204285" display_stop="129837710" Strand="+" />
          </Location>
          <OMIM>156225</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" outerStart="129381042" innerStart="129419317" innerStop="129419561" outerStop="129465045" display_start="129381042" display_stop="129465045" variantLength="84004" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(129381042_129419317)_(129419561_129465045)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del AND LAMA2-related muscular dystrophy" Accession="RCV003331964" Version="1">
        <ClassifiedConditionList TraitSetID="9616">
          <ClassifiedCondition DB="MedGen" ID="C5679788">LAMA2-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24611677</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30301903</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16601" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Laminin alpha 2-related dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">LAMA2-related muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0100228" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LAMA2-RD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="C5679788" DB="MedGen" />
              <XRef ID="MONDO:0100228" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7557874" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004038393" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24611677</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30301903</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exon 4 in the LAMA2 gene. A presumed nomenclature of c.(396+1_397-1)_(639+1_640-1)del has been designated for the purposes of this classification. Although the exact breakpoints of this deletion are not known, it is expected to result in a large in-frame deletion in the LAMA2 gene, a known mechanism of disease. The variant was absent in 21694 control chromosomes (gnomAD, Structural Variant dataset). c.(396+1_397-1)_(639+1_640-1)del has been reported in the literature as a biallelic genotype in multiple individuals affected with Laminin Alpha 2-Related Dystrophy (e.g. Xiong_2015, Ge_2018). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24611677, 30301903). One ClinVar submitter has assessed a similar exon 4 deletion variant since 2014, and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(129381042_129419317)_(129419561_129465045)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13878306</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7557874" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

